卡特-T疗法:呼吸道疾病的进展
Hui Han1,2,3,4, Yongxian Hu1,2,3,4
1Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310009, China.
Chinese medical journal pulmonary and critical care medicine
|January 19, 2026
概括
化学抗原受体 (CAR) T细胞疗法显示出除了血液癌症之外的呼吸道疾病的前景. 对抗原向和瘤微环境的挑战正在通过改善治疗的新策略来解决.
科学领域:
- 免疫治疗是一种免疫疗法.
- 细胞疗法 细胞疗法
- 呼吸系统医学 呼吸系统医学
背景情况:
- 化学抗原受体 (CAR) T细胞疗法是一种采用性免疫疗法,基因工程T淋巴细胞以向特定的抗原.
- CAR-T疗法通过使MHC独立的抗原识别能够在血液恶性瘤中取得成功.
研究的目的:
- 审查CAR-T疗法在各种呼吸系统疾病中的扩展应用.
- 总结使用CAR-T治疗呼吸系统疾病的临床前和临床进展.
- 确定呼吸道疾病中CAR-T治疗的挑战和新兴策略.
主要方法:
- 对呼吸道疾病的CAR-T疗法的当前文献进行系统审查.
- 对临床前和临床进展的分析.
- 确定挑战和潜在的解决方案.
主要成果:
- 针对呼吸道恶性瘤,严重喘,传染病,异常性肺纤维化和肺自身免疫性疾病,正在研究CAR-T疗法.
- 关键的挑战包括有限的瘤特异性抗原,免疫抑制性瘤微环境以及制造/物流问题.
- 结合策略正在出现,以提高CAR-T的有效性和安全性.
结论:
- 卡特-T疗法作为耐火性呼吸道疾病的新型治疗范式具有显著的潜力.
- 克服当前的挑战对于成功的临床翻译至关重要.
- 目前的进展表明,CAR-T疗法可以在呼吸系统疾病中实现持久缓解.
相关概念视频
12:55Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
22.0K
The lymphodepletive and immunomodulatory effects of chemotherapy and radiation standard of care can be leveraged to enhance the antitumor efficacy of T cell immunotherapy. We outline a method for generating EGFRvIII-specific chimeric antigen receptor (CAR) T cells and administering them in the context of glioblastoma standard of care.
22.0K
07:33Enhancing Chimeric Antigen Receptor-Extracellular Vesicles (CAR-EV) Technology: The Future of Cancer Therapy
749
The therapeutic application of extracellular vesicles (EVs) has the potential to revolutionize cancer treatment and drug delivery. Chimeric antigen receptor (CAR) cell-derived EVs (CAR-EVs) isolated using ion-exchange chromatography exhibit increased cargo capacity, significantly enhancing their functional efficacy. This study further characterizes CAR-EVs to elucidate their biological activity and therapeutic...
749
15:48ALS - Motor Neuron Disease: Mechanism and Development of New Therapies
10.0K
Jeffrey D. Rothstein speaks about the pathology and mechanisms underlying amyotrophic lateral sclerosis or ALS, advances in ALS research, and current strategies towards the development of...
10.0K
08:19A Spheroid Killing Assay by CAR T Cells
17.1K
This protocol is designed to assess immunotherapeutic redirected T-cell (CAR T-cell) cytotoxicity against 3D structured cancerous cells (spheroids) in real...
17.1K
12:38Cortical Neurogenesis: Transitioning from Advances in the Laboratory to Cell-Based Therapies
6.6K
6.6K
23:53Ole Isacson: Development of New Therapies for Parkinson's Disease
8.4K
Ole Isacson gives a concise overview of Parkinsons's disease, its causes, therapeutic strategies, and advances in Parkinson's...
8.4K